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ABSTRACT: An unexpected C-C bond cleavage was observed in trichloroacetamide-tethered ketones under amine treatment and 
exploited to develop a new synthesis of normophans from 4-amidocyclohexanones. The reaction involves an unprecedented intra-
molecular haloform-type reaction of trichloroacetamides promoted by enamines (generated in situ from ketones) as counter-
reagents. The methodology was applied to the synthesis of compounds embodying the 6-azabicyclo[3.2.1]octane framework. 
Methodologies involving the inter- or intramolecular for-
mation of carbon-carbon bonds at the α-position of ketones 
are important tools for the construction of molecular frame-
works in organic synthesis.1 Nevertheless, to our knowledge, 
the α-carbamoylation of ketones remains an “orphan” proce-
dure.2,3 Whereas the feasibility of using intramolecular amide 
enolate alkylation (IAEA) in lactam synthesis is known,4 the 
umpolung version in which the amide carbonyl acts as an 
acceptor against an α-carbonyl (ketone) group, such as a nu-
cleophile, is unreported. The only procedures for the intramo-
lecular C-carbamoylation described to date are carbamoyl 
radical,5 electrophilic,6 and Ru-catalyzed7 cyclizations upon 
alkenes (Scheme 1). 
 
Scheme 1. Intramolecular Carbamoylation  
 
 
Figure 1. Normorphan Compounds 
   As part of our continuing interest in synthesizing lactams 
from trichloroacetamides,8 we report here an efficient method 
to synthesize the azabicyclic normorphan ring, based on an 
intramolecular carbamoylation of ketones. The 6-azabicyclo 
[3.2.1]octane (normorphan) nucleus is the backbone of pedun-
cularine9 and actinobolamine,10 and appears as a structural 
subunit in several other alkaloids.11 Additionally, various 
normorphans are pharmacologically interesting12 (Figure 1). 
   Among the vast array of synthetic procedures to achieve 
compounds embodying the 6-azabicyclo[3.2.1]octane skele-
ton,13,14 a scarcely used approach involves a ring-closing C1-
C7 bond formation. Apart from our studies on the radical 
cyclization of α-aminomethyl radicals,15 and those of Grainger 
using carbamoyl radicals,5,11 there are no other precedents for 
this disconnection in a synthetic plan toward the aforemen-





















































Scheme 2. Enol Acetate vs Enamine Formation from Tri-
chloroacetamide 1 
 
   We began with the aim of extending our methodology for 
the radical cyclization of trichloroacetamides upon electron-
rich alkenes, previously reported using enol acetates (i.e. 1A) 
as radical acceptors,8b to the corresponding enamines, i.e. 1B 
(Scheme 2). During this study, it was serendipitously discov-
ered that when ketone 18b was treated with pyrrolidine (1.2 
equiv) and a catalytic amount of TsOH in toluene at reflux, 
normorphan 2 was isolated in 68% yield (Scheme 2) instead of 
the expected enamine of 1. After this surprising result, a syn-
thetic study of the methodology toward 6-
azabicyclo[3.2.1]octanes using amine-promoted carbocycliza-
tion of trichloroacetamide-tethered ketones was undertaken. 
   Although organic reactions featuring trichloromethyl as a 
leaving group are well established (e.g., the haloform reac-
tion),16 they have not been reported from trichloroacetamides 
using enamines as nucleophiles. 
   To improve the reaction conditions, microwave heating was 
explored in initial experiments to accelerate the process. At 
120 ºC, after only 15 min, a full conversion was observed, but 
the target 2 was isolated in only a moderate yield (53%, Table 
1, Entry 1). No improvement was obtained by switching to 
acetonitrile as the solvent (Entry 2), but when the reaction was 
carried out in solvent-free mode without the TsOH catalyst 
and using conventional heating in a sealed tube, 2 was isolated 
in a better yield (78%, Entry 3). Moreover, when a substoichi-
ometric amount of pyrrolidine (0.5 equiv) was used, the yield 
improved further to reach 91-94% after only 5 min of reaction 
in a 1 g-scale synthesis (Entry 4). Finally, it was found that the 
pyrrolidine loading can be diminished to 20-25% with little 
effect on the yield (Entry 5). Additionally, the process was 
also activated by the use of primary amines (e.g. benzylamine 
and allylamine), although large amounts were required and the 
yield was lower (Entries 7-8).  
   The new type of C-C bond formation here described is prob-
ably based on a nucleophilic attack of an enamine generated in 
situ on a trichloroacetamide carbonyl group, with a concomi-
tant release of the trichoromethyl anion as a leaving group. 
Indeed, a peak corresponding to CHCl3 was observed when 
recording the NMR spectrum of the crude reaction mixture in 
deuterated benzene.  
   The applicability of the methodology was subsequently 
explored on trichloroacetamides in which the benzyl group 
was replaced by primary or α-branched alkyl groups (com-
pounds 1b-1e). We tested two reaction conditions: the solvent-
free procedure under conventional heating (Method A), used 
in the N-benzyl series, and a microwave protocol with toluene 
as a solvent (Method B, Table 1, entries 9-15). When using 
compounds other than the N-benzyl derivative 1a, Method A 
afforded lower yields than Method B, which was attributed to 
the low homogeneity of the trichloroacetamide (1b-1e) and 
pyrrolidine mixture. The microwave procedure worked very 
well with trichloroacetamides bearing linear substituents at the 
nitrogen atom, while the yield decreased when the α-position 
was branched (isopropyl or α-methylbenzyl substituents, as in 
1e and 3). 
 
Table 1. Synthesis of Normorphans 2a 
 
entry compd methoda amine    
(equiv) 
time  
(min)        
yield 
(%)b 
1 1a Bc 1.2 15 53c 
2 1a Bc 1.2 15 56c 
3 1a A 1.2 15 78 
4 1a A 0.5 5 94d 
5 1a A 0.25 5 80 
6 1a B 2 5 85 
7 1a A 1e 5 50 
8 1a A 5f 5 58g 
9 1b A 5 5 55h 
10 1b B 2 5 96 
11 1c A 1 5 78 
12 1c B 2 5 82 
12 1d A 5 10 50 
13 1d B 2 5 60 
14 1e A 1 5 71 
15 1e Bi 2 5 88 
a Unless otherwise noted, the reaction was carried out from 200 
mg of 1a or from 100 mg of 1b-1e, using pyrrolidine as the 
amine. Method A: The reaction was carried out from trichloroa-
cetamide 1 at 100 ºC in solvent-free mode. Method B: µW, 100 ºC 
in toluene (1 mL). b Yields refer to pure compounds isolated by 
flash chromatography .c At 120 ºC, µW, p-TsOH (0.06 equiv), 
and solvent (2 mL): toluene or acetonitrile (entries 1 and 2). d 1 g- 
scale. e Benzylamine was used. f Allylamine was used. g 35% of 1 
was recovered. h 31% of 1 was recovered. i 200 mg scale.  
 
   The methodology was also applied to enantiopure trichloro-
acetamide 3. Unlike 1, 3 required two equivalents of pyrroli-
dine and a prolonged reaction time to achieve a full conver-
sion, leading to the diastereomers 4 and 5 in a 1:1.3 ratio and 













































1 21a, R = Bn
1b, R = Me
1c, R = Allyl
1d, R = iPr
1e, R = CH2CH(OEt)2
 3 
Scheme 3. Cyclization of Trichloroacetamide 3 
 
   Evidence for the configuration of 4 (1S,5S) and 5 (1R,5R) 
was provided by NOESY experiments, which showed off-
diagonal cross-peaks connecting H-4eq and CH3 in 4 and H-
4eq and aromatic protons in 5. This stereochemical elucidation 
agrees with the chemical shift of H-4eq, which is shielded (δ 
1.04) in 5 with regard to 4 (δ 2.20), indicating that H-4eq is 
held below the benzene ring in 5 (see Supportin Information).  
   The two diastereomers 4 and 5 were submitted to LiAlH4 
reduction to provide the corresponding amino alcohols 6 and 
7, respectively (not shown, see SI), which after debenzylation 
gave enantiopure normorphan 8 and its enantiomer ent-8 
(Scheme 4). We then used these new sterically demanding 
secondary amines (i.e. 8)17 to explore the asymmetric organo-
catalyzed synthesis of normorphan 2. 
 
  Scheme 4. Synthesis of enantiopure 8 and ent-8 
 
   When trichloroacetamide 1 was treated with 8, the chemical 
yield of the carbamoylation was good (70% yield), but the 
enantioselectivity was very poor [(+)-2 < 20% ee). A short 
screening of organocatalysts gave disappointing results (see 
SI); although chemical yields ranged from good to excellent, 
the enantiomeric excess was again unsatisfactory, except for 
(S)-prolinamide. When the latter was used (0.5 equiv, DMSO, 
rt, 64 h), the reaction afforded  (-)-2 in 50% yield and 63% ee. 
These preliminary results are in line with previously noted 
difficulties in the organocatalyzed desymmetrization of 4-
aminocyclohexanones.18,19 
   At this point, to examine the scope of the intramolecular 
carbamoylation reaction, the synthesis of more structurally 
complex normorphan compounds was undertaken (Scheme 5). 
When the α-methyl-substituted cyclohexanone 920 was treated 
with benzylamine to promote the carbamoylation of the ke-
tone, the process took place regioselectively from the less 
substituted carbon, leading to the normorphan 10, which was 
also obtained after treating 9 with a secondary amine such as 
pyrrolidine (1.5 equiv, solvent-free, 73%). Interestingly, an 
epimerization at C3 occurred in the basic reaction medium. 
   The reaction was extended to additional substrates, including 
the azaspiranic trichloroacetamide 11,21 which led to the 
azatricyclic compound 12 as an epimeric mixture (2:1 ratio) in 
a good overall yield. This new heterocycle constitutes the ring 
core of the structurally unique pentacyclic alkaloid cephalocy-
clidin A.22 The structure of the major compound 12a was 
determined by X-ray crystallographic analysis (see SI). 
Scheme 5. Synthesis of Other Normorphans 
 
   Additionally, we were interested in extending this reaction to 
achieve the six-membered ring scaffold from trichloroacetam-
ide 1323 (Scheme 6).  However, the enlargement of the side 
chain bearing the trichloroacetamide moiety had a significant 
impact on the reaction course. Thus, treatment of 13 with 
pyrrolidine gave the anti-Bredt compound 1424 instead of 
lactam 13a. The structure of this unprecedented type of anti-
Bredt ring (3-azabicyclo[[4.3.1]dec-5-ene)25 was elucidated by 
NMR data and secured by X-ray crystallographic analysis 
(Figure 2).  
 
Scheme 6. Synthesis of anti-Bredt azabicyclo 14 
 
 
Figure 2. X-ray structure of 14  
   Not unexpectedly, trichloroacetate 15 behaved differently 
under pyrrolidine treatment, leading to the corresponding 
carbamate 16 (see ref 26).26 Thus, the presence of the nitrogen 
atom (i.e. the trichloroacetamide group) is essential for the 
accomplishment of the process since the oxygenated analog 
















































































































   In summary, a direct synthesis of the 6-
azabicyclo[3.2.1]octane ring, prevalent in a range of biologi-
cally active compounds, from an unprecedented α-
carbamoylation of ketones is reported. The process involves 
an intramolecular reaction of trichloroacetamides promoted by 
enamines (generated in situ from ketones) as counter-reagents. 
The lactam functionalization of this heterocycle promises 
several future applications, notably including the conversion 
of this building-block to the corresponding homo-derivative 
bearing a morphan nucleus.27 
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